These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9420912)

  • 1. Impact of mammographic screening on the size and the relative frequency of invasion in breast cancers seen in a community hospital from 1975-1988.
    Bennington JL; Lagios MD; Margolin FR
    Pathology (Phila); 1992; 1(1):11-21. PubMed ID: 9420912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The proportion of non-invasive (Tis) and minimal invasive cancers (T1a,b) among breast cancer in Split region].
    Bezić J; Sutlović D; Tomić S; Kuzmić-Prusac I; Alujević A; Vrbicić B
    Lijec Vjesn; 2004; 126(3-4):60-5. PubMed ID: 15506265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional and future management of nonpalpable breast cancer.
    Cady B
    Am Surg; 1997 Jan; 63(1):55-8. PubMed ID: 8985072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
    Reinier KS; Vacek PM; Geller BM
    Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
    Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
    ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.
    Wärnberg F; Bergh J; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):769-74. PubMed ID: 10498395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of breast cancers diagnosed in and outside of the large scale mammography program of the Ariana area of Tunisia].
    Zeghal D; Mahjoub S; Zakraoui MA; Zouari F
    Tunis Med; 2009 Jul; 87(7):450-3. PubMed ID: 20063678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER; Park A; Borgen PI; Morris E; Montgomery LL
    Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival rates for breast cancers detected in a community service screening mammogram program.
    Sener SF; Winchester DJ; Winchester DP; Barrera E; Bilimoria M; Brinkmann E; Alwawi E; Rabbitt S; Schermerhorn M; Du H
    Am J Surg; 2006 Mar; 191(3):406-9. PubMed ID: 16490556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic screening reduces risk of breast carcinoma recurrence.
    Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
    Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of the localization technique of occult breast changes with reference to future screening programs].
    Hess T; Benz J; Juchler A
    Helv Chir Acta; 1992 May; 59(1):263-8. PubMed ID: 1526839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting which invasive cancers at mammographic screening saves lives?
    Evans AJ; Pinder SE; Burrell HC; Ellis IO; Wilson AR
    J Med Screen; 2001; 8(2):86-90. PubMed ID: 11480449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of mammographically detected breast cancers.
    Sener SF; Winchester DJ; Winchester DP; Kurek R; Motykie G; Martz CH; Rabbitt S
    Am Surg; 1999 Aug; 65(8):731-5; discussion 735-6. PubMed ID: 10432082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.